vialroom

#bloodwork 2026-05-14

Thursday27 messages6 participantstimes are UTC
Highlights from this day
  • reta_resting_hr — homa-ir is fasting glucose times fasting insulin over a constant. the constant differs by unit system 18:54
  • VialBot — Testing queue: 6 submissions open, 34 awaiting dispatch. 20:57
  • homa_ir_hugo — how much does the lipid panel move just from losing weight 22:24
RR

apob is the better marker and it is harder to get. i track both because i can only get one reliably, for what its worth

RR

homa-ir is fasting glucose times fasting insulin over a constant. the constant differs by unit system

baseline  58
wk 2      61
wk 4      64
wk 6      67
wk 8      66
wk 10     65   (held dose from wk 7)
DE

get fasting insulin at baseline. you cannot go back and get it once you have started

ST

an isolated lipase a bit over range with no symptoms is usually nothing. lipase with severe pain is not

RR

the most useful thing i did was get a full panel before i started. everything since has been comparable

peptidemeter-summary-h-2814.pdf
2 pages · 176 KB · not retained in the public archive
HI

fast properly or do not bother. an eight hour fast and a twelve hour fast are different tests

📉1
ST

update on the earlier thing baseline, three months, then twice a year is what i settled on, i think

a small egfr dip is often dehydration. rehydrate and retest before you panic

VB

Reminder for tga_notice: dose day is today. Set 3 days ago.

DE

egfr dropped a few points, dehydration or something real

if a result frightens you, that is a conversation with a clinician. we will help you read it, we will not tell you it is fine

TN

if you only get one thing, get a fasting insulin. it is the one that becomes impossible later

right so apob or ldl, which one are you all actually tracking

😂1👀4

Testing queue: 6 submissions open, 34 awaiting dispatch.

❤️15
HI

a1c is a ninety day average. retesting at week six tells you almost nothing

how much does the lipid panel move just from losing weight

Cited study
Once-Weekly Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes (STEP 2)
The Lancet · 2021
The type 2 diabetes population, where the weight response is generally smaller.